End-of-day quote
Korea S.E.
06:00:00 2024-06-06 pm EDT
|
5-day change
|
1st Jan Change
|
5,260
KRW
|
+1.35%
|
|
+1.35%
|
+1.74%
|
Fiscal Period: December |
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
---|
Capitalization
1 |
143,821
|
140,652
|
167,710
|
174,779
|
133,827
|
126,026
|
Enterprise Value (EV)
1 |
100,431
|
103,310
|
115,713
|
95,265
|
56,854
|
22,903
|
P/E ratio
|
29.4
x
|
19.4
x
|
25.1
x
|
7.73
x
|
1,098
x
|
6.59
x
|
Yield
|
-
|
-
|
-
|
-
|
-
|
-
|
Capitalization / Revenue
|
2.24
x
|
1.89
x
|
2.39
x
|
2.24
x
|
1.52
x
|
1.37
x
|
EV / Revenue
|
1.56
x
|
1.39
x
|
1.65
x
|
1.22
x
|
0.64
x
|
0.25
x
|
EV / EBITDA
|
19.9
x
|
10.7
x
|
12.4
x
|
10.1
x
|
5.46
x
|
2.77
x
|
EV / FCF
|
20.9
x
|
-12.8
x
|
10.3
x
|
11
x
|
9.27
x
|
3.27
x
|
FCF Yield
|
4.78%
|
-7.84%
|
9.72%
|
9.11%
|
10.8%
|
30.6%
|
Price to Book
|
1.86
x
|
1.66
x
|
1.84
x
|
1.54
x
|
1.16
x
|
0.94
x
|
Nbr of stocks (in thousands)
|
24,376
|
24,376
|
24,376
|
24,376
|
24,376
|
24,376
|
Reference price
2 |
5,900
|
5,770
|
6,880
|
7,170
|
5,490
|
5,170
|
Announcement Date
|
3/20/19
|
3/18/20
|
3/18/21
|
3/23/22
|
3/23/23
|
3/21/24
|
Fiscal Period: December |
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
---|
Net sales
1 |
64,315
|
74,267
|
70,069
|
78,170
|
88,286
|
92,019
|
EBITDA
1 |
5,042
|
9,616
|
9,300
|
9,468
|
10,418
|
8,271
|
EBIT
1 |
2,350
|
7,072
|
7,171
|
7,108
|
7,857
|
5,773
|
Operating Margin
|
3.65%
|
9.52%
|
10.23%
|
9.09%
|
8.9%
|
6.27%
|
Earnings before Tax (EBT)
1 |
5,321
|
7,742
|
8,312
|
26,025
|
-3,095
|
23,446
|
Net income
1 |
4,931
|
7,247
|
6,683
|
22,656
|
131.6
|
19,139
|
Net margin
|
7.67%
|
9.76%
|
9.54%
|
28.98%
|
0.15%
|
20.8%
|
EPS
2 |
201.0
|
297.0
|
274.0
|
928.0
|
5.000
|
785.0
|
Free Cash Flow
1 |
4,805
|
-8,097
|
11,251
|
8,680
|
6,131
|
7,005
|
FCF margin
|
7.47%
|
-10.9%
|
16.06%
|
11.1%
|
6.94%
|
7.61%
|
FCF Conversion (EBITDA)
|
95.32%
|
-
|
120.97%
|
91.68%
|
58.86%
|
84.7%
|
FCF Conversion (Net income)
|
97.44%
|
-
|
168.35%
|
38.31%
|
4,660.28%
|
36.6%
|
Dividend per Share
|
-
|
-
|
-
|
-
|
-
|
-
|
Announcement Date
|
3/20/19
|
3/18/20
|
3/18/21
|
3/23/22
|
3/23/23
|
3/21/24
|
Fiscal Period: December |
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
---|
Net Debt
1 |
-
|
-
|
-
|
-
|
-
|
-
|
Net Cash position
1 |
43,391
|
37,342
|
51,997
|
79,515
|
76,973
|
103,123
|
Leverage (Debt/EBITDA)
|
-
|
-
|
-
|
-
|
-
|
-
|
Free Cash Flow
1 |
4,805
|
-8,097
|
11,251
|
8,680
|
6,131
|
7,005
|
ROE (net income / shareholders' equity)
|
6.56%
|
9.02%
|
7.61%
|
22.2%
|
0.14%
|
15.7%
|
ROA (Net income/ Total Assets)
|
1.61%
|
4.43%
|
3.96%
|
3.37%
|
3.35%
|
2.22%
|
Assets
1 |
307,060
|
163,451
|
168,718
|
671,482
|
3,929
|
860,545
|
Book Value Per Share
2 |
3,170
|
3,472
|
3,740
|
4,662
|
4,723
|
5,498
|
Cash Flow per Share
2 |
547.0
|
568.0
|
1,569
|
537.0
|
1,287
|
561.0
|
Capex
1 |
399
|
17,008
|
1,200
|
521
|
471
|
660
|
Capex / Sales
|
0.62%
|
22.9%
|
1.71%
|
0.67%
|
0.53%
|
0.72%
|
Announcement Date
|
3/20/19
|
3/18/20
|
3/18/21
|
3/23/22
|
3/23/23
|
3/21/24
|
|
1st Jan change
|
Capi.
|
---|
| +1.74% | 92.67M | | -11.43% | 13.71B | | -44.31% | 2.56B | | -13.72% | 2.35B | | -21.19% | 1.3B | | -.--% | 1.12B | | +94.36% | 511M | | +23.08% | 468M | | +31.39% | 285M | | -11.03% | 205M |
Medical Imaging Systems
|